Evidence map›Paper›PMID 39790821›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Role of [18F]FDG-PET/CT in Evaluation of Tumor Response to Chemoradiation Therapy for Advanced Colorectal Cancer.

Abhishek Soni, Stuti Chandola, Chandan Jyoti Das, Raju Sharma, Sushmita Pathy, Hemanaga Kumar Bhattacharjee, Sheragaru Hanumanthappa Chandrashekhara, Atul Sharma, Rakesh Kumar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abhishek SoniDepartment of Radio-Diagnosis and Interventional Radiology, All India Institute of Medical Sciences, New Delhi, India.
Stuti ChandolaDepartment of Radio-Diagnosis and Interventional Radiology, All India Institute of Medical Sciences, New Delhi, India.
Chandan Jyoti DasDepartment of Radio-Diagnosis and Interventional Radiology, All India Institute of Medical Sciences, New Delhi, India.
Raju SharmaDepartment of Radio-Diagnosis and Interventional Radiology, All India Institute of Medical Sciences, New Delhi, India.
Sushmita PathyDepartment of Radiation Oncology, BRAIRCH, All India Institute of Medical Sciences, New Delhi, India.
Hemanaga Kumar BhattacharjeeDepartment of Surgical Discipline, All India Institute of Medical Sciences, New Delhi, India.
Sheragaru Hanumanthappa ChandrashekharaDepartment of Radio-Diagnosis, BRAIRCH, All India Institute of Medical Sciences, New Delhi, India.
Atul SharmaDepartment of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Rakesh KumarDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The objective is to evaluate the efficacy of Materials and Methods: Fifty patients with advanced rectal cancer underwent two point imaging with 18 FDG PET-CT before and after 3 weeks of completion of preoperative/palliative CRT in between 2016 and 2022. Patients with locally recurrent cancer also underwent radical surgery. The assessment consisted of the evaluation of the following metabolic PET parameters: Maximum standardized uptake value (SUV Observations and Results: There was a significant decline in the mean post therapy SUV Conclusion: PET-CT is a useful combined anatomic and functional imaging modality in monitoring tumor response to preoperative/palliative CRT in advanced rectal cancer, whether primary or recurrent, including metastatic cancers at presentation. Posttherapy SUV and TLG in particular are significantly associated with treatment response.

Indexed as

18F-fluorodeoxyglucose positron emission tomography computed tomographyadvanced colorectal cancerrecurrent colorectal cancer

Identifiers

PMID39790821
PMCPMC11708798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.